Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioDevek is a private biomaterials and medical device company developing tissue-responsive, degradable hydrogel technologies for surgical and endoscopic applications. Its lead product, GastroShield, is designed to provide rapid hemostasis and durable mucosal protection during gastrointestinal endoscopy, particularly for bleeding control and shielding high-risk lesions. The company’s core platform consists of sprayable or injectable biomaterials that adhere to wet tissue, remain transparent for visualization, and degrade in a controlled manner. BioDevek emerged from more than a decade of MIT materials science and tissue engineering research and is applying its platform to improve healing and reduce complications after internal procedures. The platform may also support localized drug delivery in future applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioDevek.